AOCOPM 2024 Midyear Educational Conference-346719

Video Transcription

Video Summary

Dr. Ferguson, a renowned medical director and expert in addiction medicine and medical review, delivered a talk focusing on the evolving role of Medical Review Officers (MROs) in drug testing, particularly in relation to federal and non-federal programs. He highlighted the need for MRO practice to adapt, emphasizing the potential integration of more fit-for-duty evaluations into their roles as the landscape of drug legality changes, such as the descheduling of marijuana. Dr. Ferguson explained that while urine remains the primary specimen for testing, oral fluid testing is on the horizon, albeit delayed by certification and FDA clearance issues.<br /><br />He detailed the changes in opiate testing guidelines, noting that the old benefit of the doubt for poppy seed ingestion is no longer applicable in HHS guidelines, though it remains for DOT pending further rule changes. He also discussed the increasing reliability on MRO assistants for verifying prescriptions, which allows for a more streamlined process amidst stringent federal regulations. While federal guidelines for oral fluid testing await lab certifications, labs are hesitant due to stringent FDA device certification processes.<br /><br />Dr. Ferguson encouraged those in attendance to pursue or renew their MRO certification, highlighting the significance of MROs amid evolving drug testing protocols and societal changes.

Keywords

Medical Review Officers

drug testing

addiction medicine

fit-for-duty evaluations

marijuana descheduling

urine testing

oral fluid testing

opiate testing guidelines

MRO certification